HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LEADS BIOLABS-B

59.750

+0.2500.42%

Volume:273.40K

Turnover:16.04M

Market Cap:11.89B

PE:-29.76

High:60.400

Open:59.000

Low:57.200

Close:59.500

52wk High:83.600

52wk Low:51.600

Shares:199.00M

HK Float Shares:153.00M

Volume Ratio:1.62

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.008

ROE:--

ROA:--

PB:103.54

PE(LYR):-29.76

PS:- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Nanjing Leads Biolabs (9887) Announces First Patient Dosed in Phase II Trial for First-Line Hepatocellular Carcinoma

Bulletin Express

LEADS BIOLABS-B (09887): First Patient Dosed in Phase II Trial of LBL-024 as First-Line Treatment for Hepatocellular Carcinoma

Nanjing Leads Biolabs Doses First Patient in Phase II Trial of LBL-024 for Liver Cancer

HK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09887"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"LEADS BIOLABS-B","latestPrice":59.75,"timestamp":1763091168634,"preClose":59.5,"halted":0,"volume":273400,"delay":0,"floatShares":153000000,"shares":199000000,"eps":-2.008042,"marketStatus":"Trading","change":0.25,"latestTime":"11-14 11:32:50","open":59,"high":60.4,"low":57.2,"amount":16037950,"amplitude":0.053782,"askPrice":59.95,"askSize":1800,"bidPrice":59.75,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.858667,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1763092800000},"marketStatusCode":2,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":59.5,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.618163,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":153000000,"roa":"--","roe":"--","lyrEps":-2.008042,"volumeRatio":1.618163,"shares":199000000,"dividePrice":0,"high":60.4,"amplitude":0.053782,"preClose":59.5,"low":57.2,"week52Low":51.6,"pbRate":"103.54","week52High":83.6,"institutionHeld":0,"latestPrice":59.75,"committee":-0.8,"eps":-2.008042,"divideRate":0,"volume":273400,"delay":0,"ttmEps":-1.858667,"open":59,"prevYearClose":35,"prevWeekClose":58.45,"prevMonthClose":53.7,"prevQuarterClose":69.95,"fiveDayClose":58.45,"twentyDayClose":66.25,"sixtyDayClose":73.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1762185600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2025-11-12","current":-32.012189,"percent":0.933333,"low":-50.052922,"twenty":-44.115151,"median":-41.529709,"eighty":-39.201212,"high":-34.030535,"avg":-41.427746,"sd":3.156628,"marketCap":11416389320},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-12","current":-36.397343,"twenty":-44.115151,"median":-41.529709,"eighty":-39.201212,"marketCap":11416389320}],"updateTime":1763059415624},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1101918459","title":"Nanjing Leads Biolabs (9887) Announces First Patient Dosed in Phase II Trial for First-Line Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1101918459","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101918459?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:54","pubTimestamp":1762764870,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited do not accept responsibility for the contents of the original announcement, make no representation as to its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1179684957","title":"LEADS BIOLABS-B (09887): First Patient Dosed in Phase II Trial of LBL-024 as First-Line Treatment for Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1179684957","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179684957?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:46","pubTimestamp":1762764384,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) announced that the first patient has been successfully dosed in a Phase II clinical study evaluating oplitelimab (PD-L1/4-1BB bispecific antibody LBL-024) as a first-line...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","BK1161"],"gpt_icon":0},{"id":"2582825908","title":"Nanjing Leads Biolabs Doses First Patient in Phase II Trial of LBL-024 for Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582825908","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582825908?lang=en_us&edition=fundamental","pubTime":"2025-11-10 16:41","pubTimestamp":1762764115,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co. Ltd. has announced the initiation of a Phase II clinical trial for Opamtistomig , a PD-L1/4-1BB bispecific antibody, as a first-line treatment for hepatocellular carcinoma. The first patient has been successfully dosed in this open-label, multi-center study, which is led by Professor Jian Zhou of Zhongshan Hospital, Fudan University, and is being conducted across multiple hospitals in China. The company previously received approval from the National Medical Products Administration for a single-arm registrational trial in April 2024, as well as Breakthrough Therapy Designation for LBL-024 in late-line advanced EP-NEC and Orphan Drug Designation from the U.S. FDA for neuroendocrine carcinoma. Results from this trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL8z7m1q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","BK1161"],"gpt_icon":0},{"id":"1199117456","title":"HK Stock Announcement Highlights | SOFTCARE to List Tomorrow; FIH Expects Significant Improvement in Annual Financial Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1199117456","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199117456?lang=en_us&edition=fundamental","pubTime":"2025-11-09 20:04","pubTimestamp":1762689852,"startTime":"0","endTime":"0","summary":"**Key Updates**   - **SOFTCARE (02698)**: Hong Kong public offering oversubscribed by 1,813.77 times, expected to list on November 10.   - **HENGRUI PHARMA (01276)**: HRS-2430 and SHR-4610 injections...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","LU0359201885.HKD","02038","BK1160","00434","LU1023057109.AUD","BK1526","LU0359201612.USD","BK1161","02698","BK1612","09887","BK1191","BK1508","BK1504","01276","BK1531","BK1104","BK1167","LU0359202008.SGD"],"gpt_icon":1}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":51,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/09887\",params:#limit:6,delay:false,,,undefined,":[]}}